Natixis Advisors’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
Other funds holding DXCM
VCM
VPM
Natixis Advisors's DXCM Position: Q1 2026 in Review
Natixis Advisors increased its DexCom (DXCM) stake by 29% in Q1 2026, buying an estimated $559K and bringing the position to 36,086 shares worth $2.27M. The position accounts for ﹤0.01% of the portfolio, ranked #1073.
Natixis Advisors first reported a position in DXCM in Q1 2014 and has held it in 18 quarters since. The position peaked at $160M in Q1 2024. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.
- Natixis Advisors held 36,086 shares of DexCom worth $2.27M as of Q1 2026.
- Natixis Advisors bought 8,025 DexCom shares in Q1 2026, an estimated $559K.
- DexCom made up ﹤0.01% of Natixis Advisors's portfolio in Q1 2026, its #1073 holding.
- Natixis Advisors first reported a position in DexCom in Q1 2014 and has held it in 18 quarters since.
- Natixis Advisors's DexCom position peaked at $160M in Q1 2024.
- 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.
Based on Natixis Advisors's 13F filing for Q1 2026, filed 13 May 2026.